The most recent issue of the Clinical Gastroenterology & Hepatology investigates the diagnostic accuracy of computed tomography using lower doses of radiation for patients with Crohn's disease.
The most recent issue of Clinical Gastroenterology & Hepatology reviews findings of endoscopic surveys in the general population with regard to gastroesophageal reflux disease.
The latest issue of Hepatology investigates the prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin.
Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis, reports August's issue of Gastroenterology.
Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer, reports the latest issue of Inflammatory Bowel Disease.
The latest issue of the Alimentary Pharmacology & Therapeutics investigates whether the concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin.
The most recent issue of the Alimentary Pharmacology & Therapeutics investigates the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients.
Whatever the primary indication, excessive alcohol consumption after liver transplantation impacts on long-term survival, reports the latest Journal of Hepatology.
The most recent issue of Inflammatory Bowel Diseases investigates the efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease.
August's issue of the Alimentary Pharmacology & Therapeutics examines established concepts and future directions of vitamin D and inflammatory bowel disease.
This week's issue of the Journal of the American Medical Association investigates relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
A study in the latest issue of the Journal of Hepatology identifies factors that better predict mortality than MELDNa in patients with cirrhosis and refractory ascites.
The latest publication of Alimentary Pharmacology & Therapeutics reviews the non-malignant haematological complications of anti-tumor necrosis factor alpha therapy.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .